Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium bromide inhalation powder vs Spiriva in COPD (Phase III, China)
CTR20240043Phase 3Completed
- Sponsor
- Puruite Pharmaceutical
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Puruite Pharmaceutical. Started Jan 2024; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20240043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240043.